Department of Neurology - Inflammatory Disorders of the Nervous System and Neurooncology, University of Muenster, Albert-Schweitzer-Campus 1, 48149 Muenster, Germany.
J Neuroinflammation. 2012 Feb 28;9:41. doi: 10.1186/1742-2094-9-41.
CD4(+) CD25(+) forkhead box P3 (FoxP3)(+) regulatory T cells (T reg cells) are known to suppress adaptive immune responses, key control tolerance and autoimmunity.
We challenged the role of CD4(+) T reg cells in suppressing established CD8(+) T effector cell responses by using the OT-I/II system in vitro and an OT-I-mediated, oligodendrocyte directed ex vivo model (ODC-OVA model).
CD4(+) T reg cells dampened cytotoxicity of an ongoing CD8(+) T effector cell attack in vitro and within intact central nervous system tissue ex vivo. However, their suppressive effect was limited by the strength of the antigen signal delivered to the CD8(+) T effector cells and the ratio of regulatory to effector T cells. CD8(+) T effector cell suppression required T cell receptor-mediated activation together with costimulation of CD4(+) T reg cells, but following activation, suppression did not require restimulation and was antigen non-specific.
Our results suggest that CD4(+) T reg cells are capable of suppressing CD8(+) T effector cell responses at the parenchymal site, that is, limiting parenchymal damage in autoimmune central nervous system inflammation.
CD4(+) CD25(+) 叉头框 P3(FoxP3)(+) 调节性 T 细胞(Treg 细胞)已知可抑制适应性免疫应答,是关键的耐受和自身免疫控制机制。
我们通过体外的 OT-I/II 系统和体外的、针对少突胶质细胞的 OT-I 介导模型(ODC-OVA 模型),研究了 CD4(+) Treg 细胞在抑制已建立的 CD8(+) T 效应细胞反应中的作用。
CD4(+) Treg 细胞在体外和完整的中枢神经系统组织中抑制了正在进行的 CD8(+) T 效应细胞攻击的细胞毒性。然而,它们的抑制作用受到传递给 CD8(+) T 效应细胞的抗原信号的强度和调节性与效应性 T 细胞的比例的限制。CD8(+) T 效应细胞的抑制需要 T 细胞受体介导的激活以及 CD4(+) Treg 细胞的共刺激,但在激活后,抑制不需要再刺激并且是非抗原特异性的。
我们的结果表明,CD4(+) Treg 细胞能够在实质部位抑制 CD8(+) T 效应细胞反应,即限制自身免疫性中枢神经系统炎症中的实质损伤。